Health Status Clinical Trials

3 recruiting

Health Status Trials at a Glance

13 actively recruiting trials for health status are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Columbia, Barcelona, and Bologna. Lead sponsors running health status studies include University of South Carolina, CSIRO Digital Productivity Flagship, and Assistance Publique - Hôpitaux de Paris.

Browse health status trials by phase

Treatments under study

About Health Status Clinical Trials

Looking for clinical trials for Health Status? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Health Status trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Health Status clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Prospective Cohort Study of Protected Children

Child DevelopmentMental Health ConditionsPhysical Health Status
Assistance Publique - Hôpitaux de Paris220 enrolled7 locationsNCT06805682
Recruiting
Not Applicable

Artificial Intelligence Satisfaction in Professionals and Patients

General Health Status
Universidad Autonoma de Madrid148 enrolled2 locationsNCT06726447
Recruiting

Enhancing Management Algorithms for Children Conceived Via Assisted Reproductive Technologies

ARTChildrenAnthropometric Characteristics+3 more
Kazakhstan's Medical University "KSPH"300 enrolled1 locationNCT07278960
Recruiting

Cohort of Nursing Homes

Health Status
Institute of Hematology & Blood Diseases Hospital, China1,500 enrolled1 locationNCT07249086
Recruiting

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Cardiovascular (CV) RiskCardiovascular Disease PreventionCardiovascular Disease (CVD)+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna500 enrolled1 locationNCT07187947
Recruiting

Assessment of Overall Functioning in Patients With Complex Health Issues

Surveys and QuestionnairesMuscle StrengthActivities of Daily Living+4 more
University Hospital Bispebjerg and Frederiksberg100 enrolled1 locationNCT06410014
Recruiting
Phase 2

Healthy Kids Beyond the Bell: Investigating the Impact of After-School and Summer Programs

Pediatric ObesityHealth Status DisparitiesSocioeconomic Factors+1 more
University of South Carolina480 enrolled1 locationNCT05880901
Recruiting
Phase 2

Determining the Optimal Amount of Structured Environments for Healthy Kids

Pediatric ObesityHealth Status DisparitiesEthnic Groups+1 more
University of South Carolina360 enrolled1 locationNCT06158594
Recruiting

AnovaOS Network Powered Patient Registry

NeoplasmsDiseases of the Circulatory SystemInfectious Disease+18 more
Anova Enterprises, Inc100,000 enrolled1 locationNCT05013944
Recruiting
Not Applicable

HIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and Children

PregnancyNoncommunicable DiseasesPostpartum+5 more
Gdansk University of Physical Education and Sport600 enrolled1 locationNCT05009433
Recruiting

Smarter, Safer Homes for the Ageing and Disabled Person Pilot Study to investigate the feasibility, acceptance, usage and impact of providing a smart home platform with environmental sensors and mobile techniques to facilitate safe living of older and disabled Australians.

Monitoring and deriving relevant information of health status in elderly participants/young people with disability to enable independent living and support from family/relative or health care provider
CSIRO Digital Productivity Flagship5 enrolled1 locationACTRN12615000029594
Recruiting

Improving maternal and infant outcomes: A multicentre randomised controlled trial of midwifery and dental intervention

Oral health status in pregnant women
Centre for Applied Nursing Research- University of Western Sydney/South Western Sydney Local Health District/Ingham Institute of Applied Medical Research630 enrolled1 locationACTRN12612001271897
Recruiting
Phase 4

A single-arm, open-label, pilot study evaluating the efficacy and safety of directly observed peginterferon alfa-2a with ribavirin in conjunction with a peer counsellor in patients actively using injecting drugs who have chronic hepatitis C and attend a drug and alcohol centre.

Chronic hepatitis C virus (HCV) infection.Side effects related to chronic Hepatitis C virus (HCV) infection and treatment in active injecting drug users (IDUs).Factors affecting compliance of active injecting drug users (IDUs) for standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection.+1 more
Dr Joe Sasadeusz50 enrolled1 locationACTRN12608000400369